TOP 5 US STOCKS WORTH INVESTING
The stock market has been pretty volatile since the beginning of 2022. The prevalent pandemic-induced inflation, and the oil price surge on the Russia-Ukraine tension are some of the major headwinds affecting the market. While investors are struggling to understand the uncertain market trends, a number of companies are still recovering or bullying their way back in the game.
Some of these stocks are the best stocks to buy today USA. We’ll have a detailed look at each one of them.
- ALPHABET INC.
Alphabet Inc., based in Mountain View, California, is an American global technological conglomerate holding company. On October 2, 2015, it was formed as a result of Google’s restructuring, and is now the parent organisation of Google and numerous previous subsidiaries. The size of its primary online video platform, YouTube, is a remarkable indication of its scale. YouTube generated $8.6 billion in revenues in the fourth quarter of 2021, roughly $1 billion more than Netflix Inc. (NFLX) during the same period.
Alphabet’s main search engine and cloud division are the only significant operations that investors have a stake in. Despite solid quarterly earnings and the sanction of a 20-for-1 stock split in July, equities are still down in 2022, due to a shift away from growth and technology stocks. GOOGLE is priced for about 24 times profits, a bargain compared to the S&P 500’s multiple of 25. After the company’s yearly assessment on April 8, the yearly return was –8%.
- MEDIFAST INC. (MED)
Medifast, Inc. is a Baltimore, Maryland-based nutrition and weight-loss company. Medifast manufactures, distributes, and sells weight-loss and health-related goods via the Internet, multi-level advertising, telemarketing, and franchised weight-loss clinics. MED is the smallest firm on this list, with a market value of roughly $2 billion, paying the highest dividend amongst some of the best stocks to buy, at 3.6%. With an impeccable financial account, a long track record of development, and predicted sales growth of 15% and 13.7% in 2022 and 2023, MED’s business appears inexpensive at just 13 times earnings. This March, Medifast increased its dividend payout by 15%. The stock has about 87% upside potential from its 52-week highs for investors looking for an under-the-radar investment with solid upside potential. After the company’s yearly assessment, the return was recorded to be –13.4%.
- ASML HOLDING NV
Advanced Semiconductor Materials Lithography, better known as ASML Holding NV, is a Dutch multinational firm specialising in the research and manufacture of photolithography technologies used to manufacture computer chips. It was formed in 1984. Its shares have been indiscriminately bought off, along with the rest of the tech sector, and pounded by the shift from growth to value, hovering barely 10% above 52-week lows. In the meantime, the corporation’s competitive landscape and bullish thesis have remained largely unchanged: ASML still holds a global dominance on extreme ultraviolet, or EUV, lithography machines. EUVs are massive high-tech devices that etch increasingly microscopic patterns on microchips. EUVs are selling for around $150 million per, with no signs of containing the global semiconductor crunch. After the company’s yearly assessment, the return was recorded as –23.3%.
- EOG RESOURCES INC.
EOG Resources, Inc. is a hydrocarbon exploration business based in the United States. It was founded in Delaware and is based in Houston’s Heritage Plaza skyscraper. The company is placed 337th on the Forbes Global 2000 and 186th on the Fortune 500. The equity mutual fund company increased 5% year over year, or 35.2% on a two-year basis. Unfortunately, Russia’s invasion of Ukraine occurred only a day later, causing the market to crash. While the mutual fund market remains hot in terms of prices, sales are slowing, with a slow down of 7.2 % in February compared to the previous month. Due to its extraordinary accomplishments, the company recently issued a special distribution of $1 per share, or 0.9 % of its share price at the time. After the yearly assessment, the return was recorded as +45.1%.
- ADITYA BIRLA MULTICAP FUND
Aditya Birla Multicap Fund is a mutual fund company based in India that sells several equity mutual fund schemes through its locations. This mutual fund scheme is part of the Aditya Birla Sun Life Mutual Fund. The company provides a full range of mutual fund choices suitable for those who wish to reap high returns through long-term investments. Aditya Birla Multicap Fund had a strong quarter in February, exceeding profitability estimates and upping full-year guidance for 2022.
BiopharmIQ is a comprehensive intelligence platform utilized by biopharmaceutical professionals to access real-time data, market insights, and competitive analysis. It empowers users to make informed decisions, optimize their strategies, and stay ahead in the dynamic landscape of the biopharmaceutical industry.
OG Resources, a U.S. oil and natural gas producer, is the greatest of U.S. News’ 10 best stocks to buy for 2022. EOG, chosen primarily as a hedge against rising inflation, has outperformed the market, rising 45%, year to date, as energy prices have risen – crude oil briefly surpassed $123 a barrel – and inflation has continued to rise, with the consumer price index reaching 40-year highs of 7.9% year-over-year growth in February and 8.5% in March. Even in the fourth quarter of 2021, EOG was humming, with adjusted earnings per share, or EPS, up 335%, year over year. The equity mutual fund company increased 5%, year over year, or 35.2% on a two-year basis. Unfortunately, Russia’s invasion of Ukraine occurred only a day later, causing the market to crash. While the mutual funds market remains hot in terms of prices, sales are slowing, with a slow down of 7.2% in February compared to the previous month. Although the Aditya Birla Multicap Fund is still booming, rising interest rates and their potential impact on the mutual fund market might be scaring investors. Also, the Aditya Birla Multicap Fund has been listed as a high-risk mutual fund scheme; however, it promises higher returns.